Effects of dexmedetomidine on perioperative stress response, inflammation and immune function in patients with different degrees of liver cirrhosis

Wang,Lianzhu; Zhang,Anjun; Liu,Wei; Liu,Hui; Su,Fan; Qi,Ling

doi:10.3892/etm.2018.6665

Effects of dexmedetomidine on perioperative stress response, inflammation and immune function in patients with different degrees of liver cirrhosis

Authors:
- Lianzhu Wang
- Anjun Zhang
- Wei Liu
- Hui Liu
- Fan Su
- Ling Qi
View Affiliations

Affiliations: Department of Anesthesiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Department of Anesthesiology, Rizhao City Hospital of Traditional Chinese Medicine, Rizhao, Shandong 276800, P.R. China, Department of Anesthesiology, Jinan Maternity and Child Care Hospital, Jinan, Shandong 250001, P.R. China, Department of Nursing, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Department of Anesthesiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Department of Anesthesiology, Jinan Maternity and Child Care Hospital, Jinan, Shandong 250001, P.R. China
Published online on: August 29, 2018 https://doi.org/10.3892/etm.2018.6665
Pages: 3869-3874
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Effects of dexmedetomidine (DEX) on perioperative stress response, inflammation and immune function in patients with different degrees of liver cirrhosis were investigated. A total of 94 patients with liver cirrhosis who were admitted to the Affiliated Hospital of Shandong University of Traditional Chinese Medicine from December 2016 to November 2017 were included, and randomly divided into control and observation group (n=47). Patients in control group were given remifentanil for anesthesia, while patients in observation group were treated with remifentanil and for DEX anesthesia. Venous blood was collected immediately before induction of anesthesia (T1), 10 min (T2) after the beginning of surgery, immediately after surgery (T3) and 2 h after surgery (T4). Hemodynamic parameters, stress response factors, adverse reactions and levels of inflammatory cytokines and T lymphocyte subsets were compared between the two groups. The mean arterial pressure in both groups was lower at T2‑T4 than that at T1 (p<0.05), and mean arterial pressure was lower in observation group than in control group (p<0.05). Visual analogue pain score (VAS) of observation group was significantly lower than that of control group at 6, 12 and 24 h after operation (p<0.05). There was no significant difference between the two groups in incidence of nausea, vomiting, hypoxemia and delayed awakening (p>0.05). Incidence of postoperative agitation in observation group was significantly lower than that in control group (p<0.05). The levels of CD3+, CD4+, and CD4+/CD8+ in both groups were significantly lower at T2‑T4 than those at T1 (p<0.05). Levels of IL‑10 and TNF‑α in both groups were significantly higher at T2‑T4 than those at T1, but levels of IL‑2 and TNF‑α were significantly lower in observation group than in control group (p<0.05). In conclusion, the use of DEX for anesthesia in patients with liver cirrhosis can improve hemodynamic stability, reduce stress response and reduce inflammation level without affecting immune function, which has important clinical significance.

View Figures

View References

1	Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, et al: ASTRAL-4 Investigators: Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis. N Engl J Med. 373:2618–2628. 2015. View Article : Google Scholar : PubMed/NCBI
2	Reddy KR, Bourlière M, Sulkowski M, Omata M, Zeuzem S, Feld JJ, Lawitz E, Marcellin P, Welzel TM, Hyland R, et al: Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis. Hepatology. 62:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
3	Bourlière M, Bronowicki JP, de Ledinghen V, Hézode C, Zoulim F, Mathurin P, Tran A, Larrey DG, Ratziu V, Alric L, et al: Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: A randomised, double-blind, phase 2 trial (SIRIUS). Lancet Infect Dis. 15:397–404. 2015. View Article : Google Scholar : PubMed/NCBI
4	Fernández-Rodríguez CM and Gutiérrez-García ML: Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther. 5:175–182. 2014. View Article : Google Scholar : PubMed/NCBI
5	Movasseghi G, Hassani V, Mohaghegh MR, Safaeian R, Safari S, Zamani MM and Nabizadeh R: Comparison between spinal and general anesthesia in percutaneous nephrolithotomy. Anesth Pain Med. 4:e13871. 2013.PubMed/NCBI
6	Gerresheim G, Brederlau J and Schwemmer U: Dexmedetomidine in the treatment of acute alcohol withdrawal delirium. Anaesthesist. 65:525–531. 2016.(In German). View Article : Google Scholar : PubMed/NCBI
7	Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A and Volk ML: The epidemiology of cirrhosis in the United States: A population-based study. J Clin Gastroenterol. 49:690–696. 2015. View Article : Google Scholar : PubMed/NCBI
8	Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Suzuki E, Tawada A, Kanai F and Yokosuka O: Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: Safety, efficacy and prognostic factors. Invest New Drugs. 33:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
9	Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M and Hunt S: Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 62:1723–1730. 2015. View Article : Google Scholar : PubMed/NCBI
10	Foster GR, Irving WL, Cheung MC, Walker AJ, Hudson BE, Verma S, McLauchlan J, Mutimer DJ, Brown A, Gelson WT, et al HCV Research, UK, : Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol. 64:1224–1231. 2016. View Article : Google Scholar : PubMed/NCBI
11	Kim SK, Pak HN, Park JH, Choi JI, Nam MH, Jo Y and Kim YH: Non-ischaemic titrated cardiac injury caused by radiofrequency catheter ablation of atrial fibrillation mobilizes CD34-positive mononuclear cells by non-stromal cell-derived factor-1alpha mechanism. Europace. 11:1024–1031. 2009. View Article : Google Scholar : PubMed/NCBI
12	Bell MT, Agoston VA, Freeman KA, Puskas F, Herson PS, Mares J, Fullerton DA and Reece TB: Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia. J Vasc Surg. 59:1090–1097. 2014. View Article : Google Scholar : PubMed/NCBI
13	Krimins RA, Ko JC, Weil AB and Payton ME: Evaluation of anesthetic, analgesic, and cardiorespiratory effects in dogs after intramuscular administration of dexmedetomidine-butorphanol-tiletamine-zolazepam or dexmedetomidine-tramadol-ketamine drug combinations. Am J Vet Res. 73:1707–1714. 2012. View Article : Google Scholar : PubMed/NCBI
14	Nazarov R, Kondratiev A, Rumiantseva M and Petrova A: Comparison of clonidine and dexmedetomidin influence on the main indicators of hemodynamic during induction of anesthesia in neurooncological patients. Intens Care Med Exp. 3 Suppl 1:A9882015. View Article : Google Scholar
15	Markou A, Sertedaki A, Kaltsas G, Androulakis II, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, et al: Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension. J Clin Endocrinol Metab. 100:2857–2864. 2015. View Article : Google Scholar : PubMed/NCBI
16	Fang VS, Tricou BJ, Robertson A and Meltzer HY: Plasma ACTH and cortisol levels in depressed patients: Relation to dexamethasone suppression test. Life Sci. 29:931–938. 1981. View Article : Google Scholar : PubMed/NCBI
17	Funai Y, Pickering AE, Uta D, Nishikawa K, Mori T, Asada A, Imoto K and Furue H: Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: An in vivo patch-clamp analysis of analgesic mechanisms. Pain. 155:617–628. 2014. View Article : Google Scholar : PubMed/NCBI
18	Sun L, Guo R and Sun L: Dexmedetomidine for preventing sevoflurane-related emergence agitation in children: A meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand. 58:642–650. 2014. View Article : Google Scholar : PubMed/NCBI
19	Pearson AM and Lurie JD: Surgical versus nonoperative treatment: How do we choose the right approach to lumbar disk herniation? Pain Manag. 4:247–249. 2014. View Article : Google Scholar : PubMed/NCBI
20	Hung MH, Chan KC, Liu YJ, Hsu HH, Chen KC, Cheng YJ and Chen JS: Nonintubated thoracoscopic lobectomy for lung cancer using epidural anesthesia and intercostal blockade: A retrospective cohort study of 238 cases. Medicine (Baltimore). 94:e7272015. View Article : Google Scholar : PubMed/NCBI
21	Bulow NM, Colpo E, Pereira RP, Correa EF, Waczuk EP, Duarte MF and Rocha JB: Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass. Braz J Med Biol Res. 49:e46462016. View Article : Google Scholar : PubMed/NCBI